Vmn1r121 Activators
Vomeronasal 1 receptor 121 (Vmn1r121) activators constitute a diverse group of chemicals that engage various biological signaling pathways to modulate the function of this specific receptor. The Vmn1r121 belongs to the family of vomeronasal receptors, which are typically involved in the detection of pheromonal cues, contributing to a range of physiological responses. The activators of Vmn1r121 share a common feature in their ability to influence the receptor's activity, though they achieve this through varied mechanisms and pathways. Some activators interact with G protein-coupled receptors (GPCRs) that trigger intracellular signaling cascades involving the production of second messengers like inositol trisphosphate (IP3) and diacylglycerol (DAG). These second messengers facilitate the release of calcium from intracellular stores, which is a critical step in the modulation of Vmn1r121 receptor function. Other chemicals within this class operate by altering the levels of cyclic nucleotides-cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP)-through the activation or inhibition of enzymes like adenylate cyclase and phosphodiesterases. The resulting changes in cyclic nucleotide levels can lead to the activation of protein kinases that phosphorylate target proteins, thus influencing Vmn1r121 receptor signaling.
In addition to these pathways, certain Vmn1r121 activators affect receptor function by directly modulating ion channels, leading to alterations in cellular ion concentrations, particularly calcium. Calcium plays a pivotal role as a secondary messenger in various signaling processes and can influence the function of the Vmn1r121 receptor by activating a suite of calcium-dependent kinases and phosphatases. Other activators might exert their effects by binding to and modulating the activity of the receptor itself or by interacting with the receptor's cellular environment, thus affecting the receptor's ability to respond to its natural ligands. The biochemical landscape of Vmn1r121 activation is complex and is shaped by the interplay between these chemicals and the cellular machinery.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bradykinin (1-3) | 23815-91-0 | sc-391193 sc-391193A sc-391193B | 5 mg 25 mg 100 mg | $154.00 $453.00 $1393.00 | ||
Bradykinin binds to its B2 receptor, triggering a phospholipase C-mediated pathway that results in increased inositol trisphosphate (IP3) and diacylglycerol (DAG). This elevation in IP3 leads to the release of calcium from intracellular stores, potentially enhancing vomeronasal 1 receptor 121 function through calcium-dependent signaling. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine, through the H1 receptor, activates phospholipase C, which increases IP3 and DAG, leading to a rise in intracellular calcium. This calcium signaling can indirectly enhance vomeronasal 1 receptor 121 function by modulating calcium-dependent kinases and phosphatases. | ||||||
ADP | 58-64-0 | sc-507362 | 5 g | $54.00 | ||
ATP, through P2X purinergic receptors, causes a rapid influx of calcium, which can activate downstream signaling pathways that enhance vomeronasal 1 receptor 121 function via calcium-dependent mechanisms. | ||||||
3-(2-Aminoethyl)-1H-indol-5-ol | 50-67-9 | sc-298707 | 1 g | $530.00 | 3 | |
Serotonin binds to 5-HT receptors, some of which can activate adenylate cyclase, increasing cAMP levels. Elevated cAMP can enhance vomeronasal 1 receptor 121 function via cAMP-dependent protein kinase A (PKA) signaling pathways. | ||||||
L-Noradrenaline | 51-41-2 | sc-357366 sc-357366A | 1 g 5 g | $326.00 $485.00 | 3 | |
Norepinephrine, via beta-adrenergic receptors, activates adenylate cyclase, leading to increased cAMP levels, which can enhance vomeronasal 1 receptor 121 function through PKA and its downstream signaling components. | ||||||
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $51.00 $100.00 $310.00 $690.00 | 3 | |
Angiotensin II binds to AT1 receptors, stimulating phospholipase C, and increasing IP3 and DAG. The resulting calcium signaling can enhance vomeronasal 1 receptor 121 function via calcium-dependent proteins and kinases. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine can bind to D1-like receptors that activate adenylate cyclase, increasing cAMP. This increase in cAMP can enhance vomeronasal 1 receptor 121 function through PKA-mediated signaling pathways. | ||||||
Oxytocin acetate salt | 50-56-6 | sc-279938 sc-279938A sc-279938B sc-279938C sc-279938D sc-279938E | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $60.00 $180.00 $337.00 $663.00 $969.00 $1836.00 | 4 | |
Oxytocin binds to its receptor, causing the activation of phospholipase C and the subsequent increase in IP3 and DAG. The resulting calcium release can enhance vomeronasal 1 receptor 121 function through calcium-dependent signaling pathways. | ||||||
Vasopressin | 11000-17-2 | sc-356188 sc-356188A | 5 mg 25 mg | $260.00 $1040.00 | 1 | |
Vasopressin interacts with V1a receptors, activating phospholipase C, increasing IP3 and DAG, and leading to calcium release. This can enhance vomeronasal 1 receptor 121 function through subsequent calcium-dependent signaling pathways. | ||||||